Search Results - "SADATSAFAVI, M"

Refine Results
  1. 1

    The global economic burden of asthma and chronic obstructive pulmonary disease by Ehteshami-Afshar, S., FitzGerald, J. M., Doyle-Waters, M. M., Sadatsafavi, M.

    “…Non-communicable diseases are now the number one cause of disabilities and loss of life expectancy. Among them, chronic respiratory conditions constitute a…”
    Get full text
    Journal Article
  2. 2

    Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis by Fisher, J H, Kolb, M, Algamdi, M, Morisset, J, Johannson, K A, Shapera, S, Wilcox, P, To, T, Sadatsafavi, M, Manganas, H, Khalil, N, Hambly, N, Halayko, A J, Gershon, A S, Fell, C D, Cox, G, Ryerson, C J

    Published in BMC pulmonary medicine (27-11-2019)
    “…The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF) is a multi-center, prospective registry designed to study the natural history of fibrotic interstitial…”
    Get full text
    Journal Article
  3. 3

    Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study by Raymakers, Ajn, Sin, D D, Sadatsafavi, M, FitzGerald, J M, Marra, C A, Lynd, L D

    Published in Respiratory research (19-05-2020)
    “…Patients living with chronic obstructive pulmonary disease (COPD) are at an increased risk of lung cancer. A common comorbidity of COPD is cardiovascular…”
    Get full text
    Journal Article
  4. 4

    Saving in medical costs by achieving guideline‐based asthma symptom control: a population‐based study by Sadatsafavi, M., Chen, W., Tavakoli, H., Rolf, J. D., Rousseau, R., FitzGerald, J. M.

    Published in Allergy (Copenhagen) (01-03-2016)
    “…Background Asthma control is increasingly used as an outcome measure in asthma trials. Economic evaluations of asthma interventions require converting the…”
    Get full text
    Journal Article
  5. 5

    Effects of long-term inhaled corticosteroid treatment on fragility fractures in older women: the Manitoba BMD registry study by Ng, B.C., Leslie, W.D., Johnson, K.M., FitzGerald, J.M., Sadatsafavi, M., Chen, W.

    Published in Osteoporosis international (01-06-2020)
    “…Summary The effects of inhaled corticosteroids (ICS) on fracture risk in older women with chronic respiratory diseases are not well established. Our results…”
    Get full text
    Journal Article
  6. 6

    Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study by McCormick, N, Marra, C A, Sadatsafavi, M, Aviña-Zubieta, J A

    Published in Lupus (01-07-2018)
    “…Objective We estimated the incremental (extra) direct medical costs of a population-based cohort of newly diagnosed systemic lupus erythematosus (SLE) for five…”
    Get full text
    Journal Article
  7. 7

    Ten‐year trends in direct costs of asthma: a population‐based study by Tavakoli, H., FitzGerald, J. M., Chen, W., Lynd, L., Kendzerska, T., Aaron, S., Gershon, A., Marra, C., Sadatsafavi, M.

    Published in Allergy (Copenhagen) (01-02-2017)
    “…Introduction There is little information on recent trends in the economic burden of asthma. Our objective was to estimate the excess costs of asthma and their…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Are COPD Prescription Patterns Aligned with Guidelines? Evidence from a Canadian Population-Based Study by Bahremand, Taraneh, Etminan, Mahyar, Roshan-Moniri, Nardin, De Vera, Mary A, Tavakoli, Hamid, Sadatsafavi, Mohsen

    “…In contemporary guidelines for the management of Chronic Obstructive Pulmonary Disease (COPD), the history of acute exacerbations plays an important role in…”
    Get full text
    Journal Article
  10. 10

    Secular decreases in fracture rates 1986–2006 for Manitoba, Canada: a population-based analysis by Leslie, W. D., Sadatsafavi, M., Lix, L. M., Azimaee, M., Morin, S., Metge, C. J., Caetano, P.

    Published in Osteoporosis international (01-07-2011)
    “…Summary We examined trends in fracture rates over 20 years in the Province of Manitoba, Canada. Hip fractures, major low-trauma fractures, and high-trauma…”
    Get full text
    Journal Article
  11. 11

    Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada by Tavakoli, Hamid, Johnson, Kate M, FitzGerald, J Mark, Sin, Don D, Gershon, Andrea S, Kendzerska, Tetyana, Sadatsafavi, Mohsen

    “…The patterns of medication use in chronic obstructive pulmonary disease (COPD) may change over time due to the availability of new medications, updates in…”
    Get full text
    Journal Article
  12. 12

    The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline by Kerkhof, Marjan, Voorham, Jaco, Dorinsky, Paul, Cabrera, Claudia, Darken, Patrick, Kocks, Anwillem W.H, Sadatsafavi, Mohsen, Sin, Don D, Carter, Victoria, Price, David B

    “…Introduction: Early identification of preventable risk factors of COPD progression is important. Whether exacerbations have a negative impact on disease…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD by Johnson, Kate M, Safari, Abdollah, Tan, Wan C, Bourbeau, Jean, FitzGerald, J Mark, Sadatsafavi, Mohsen, Study, On Behalf Of The Canadian Cohort Of Obstructive Lung Disease CanCOLD

    “…The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung…”
    Get full text
    Journal Article
  16. 16

    Predicting Lung Transplant Waitlist Survival with the Lung Allocation Score in British Columbia, Canada by Hirji, A, Yee, J, Sadatsafavi, M, Singer, L.G, Levy, R.D

    “…Purpose The Lung Allocation Score (LAS), implemented in 2005 in the United States, allocates donor organs according to predicted pre and post-lung transplant…”
    Get full text
    Journal Article
  17. 17

    Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients--a pharmacoeconomic analysis by Wilbur, Kerry, Lynd, L D, Sadatsafavi, M

    Published in Clinical and applied thrombosis/hemostasis (01-10-2011)
    “…Prevention of in-hospital venous thromboembolism (VTE) is identified internationally as a priority to improve patient safety. Advocated alternatives include…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20